Ranking Profile - BeyondSpring Inc

Introduction

BeyondSpring Inc (BeyondSpring) is a clinical stage biopharmaceutical company that develops immune-oncology cancer therapies. The company provides lead compound, Plinabulin, is derived from a natural compound which holds a number of biochemical activities and provides multiple potential therapeutic potentials in various types of cancers; BPI-002, an oral small molecule agent used for the treatment of colon cancer; BPI-003 and BPI-004 against various tumors. Its target areas include non-small cell lung cancer, neutropenia prevention, and plinabulin with opdivo. The company holds a license from the Fred Hutchinson Cancer Research Center and University of Washington for a range of platform technology which concentrates on a novel mechanism to inhibit a various oncogenes. BeyondSpring is headquartered in New York City, New York, the US.